Literature DB >> 10369172

Neurological abnormalities, major orthopaedic deformities and ambulation analysis in a myelomeningocele population in Catalonia (Spain).

J Iborra1, E Pagès, A Cuxart.   

Abstract

UNLABELLED: The aim of the study was to analyze the present status of neurologic abnormalities, major orthopaedic deformities and ambulatory status in a large myelomeningocele population. PATIENTS AND METHODS: Cross-sectional study based on the clinical and radiographic records of 322 patients treated and followed-up from 1967-1995. The setting was a multidisciplinary spina bifida unit within a third-level university hospital, which serves as the referral centre for these patients in Catalonia (Spain). We collected information on diagnosis, central nervous system, musculoskeletal system (spinal and hip deformities) and functional level in each patient. To study relationships among the variables, the Mann-Whitney U and the Chi-squared tests were applied. Results were considered to be statistically significant at P levels of < or = 0.05.
RESULTS: Mean age was 15.9 years. 78.1% of patients had mid-lumbar, low-lumbar or sacral neurological levels; 97.5% had hydrocephalus and 68.8% were shunted. Prevalence of spine deformities was 45.3%; 38.8% had dislocation of one or both hips. Median age of walking onset was 37.1 months and 74.8% of patients were ambulatory. Median age at which ambulation ceased was 128 months (10 years and 8 months). The bivariate analysis showed statistically significant relationships between neurological level and all the variables studied (P<0.001, P<0.02) except body mass indexes and intelligence quotient.
CONCLUSIONS: Neurological level was the main factor that determined neurological abnormalities, major orthopaedic deformities and ambulatory status.

Entities:  

Mesh:

Year:  1999        PMID: 10369172     DOI: 10.1038/sj.sc.3100815

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  8 in total

1.  Ambulation in adults with myelomeningocele. Is it possible to predict the level of ambulation in early life?

Authors:  Aase Seitzberg; Marianne Lind; Fin Biering-Sørensen
Journal:  Childs Nerv Syst       Date:  2007-08-21       Impact factor: 1.475

2.  Ambulation, lesion level, and health-related quality of life in children with myelomeningocele.

Authors:  Ebru Şeker Abanoz; Meral Özmen; Mine Çalışkan; Gülbin Gökçay; Nur Aydınlı
Journal:  Childs Nerv Syst       Date:  2019-08-19       Impact factor: 1.475

Review 3.  Who needs surgery for pediatric myelomeningocele? A retrospective study and literature review.

Authors:  Humberto Marreiros; Clara Loff; Eulália Calado
Journal:  J Spinal Cord Med       Date:  2014-07-16       Impact factor: 1.985

4.  Impact of enhanced sensory input on treadmill step frequency: infants born with myelomeningocele.

Authors:  Annette Pantall; Caroline Teulier; Beth A Smith; Victoria Moerchen; Beverly D Ulrich
Journal:  Pediatr Phys Ther       Date:  2011       Impact factor: 3.049

5.  Approximate entropy values demonstrate impaired neuromotor control of spontaneous leg activity in infants with myelomeningocele.

Authors:  Beth A Smith; Caroline Teulier; Jennifer Sansom; Nicholas Stergiou; Beverly D Ulrich
Journal:  Pediatr Phys Ther       Date:  2011       Impact factor: 3.049

6.  Stepping responses of infants with myelomeningocele when supported on a motorized treadmill.

Authors:  Caroline Teulier; Beth A Smith; Masayoshi Kubo; Chia-Lin Chang; Victoria Moerchen; Karin Murazko; Beverly D Ulrich
Journal:  Phys Ther       Date:  2008-12-04

7.  Changes in muscle activation patterns in response to enhanced sensory input during treadmill stepping in infants born with myelomeningocele.

Authors:  Annette Pantall; Caroline Teulier; Beverly D Ulrich
Journal:  Hum Mov Sci       Date:  2012-11-15       Impact factor: 2.161

8.  Muscle activation patterns in infants with myelomeningocele stepping on a treadmill.

Authors:  Jennifer K Sansom; Caroline Teulier; Beth A Smith; Victoria Moerchen; Karin Muraszko; Beverly D Ulrich
Journal:  Pediatr Phys Ther       Date:  2013       Impact factor: 3.049

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.